Researchers have examined the link between alcohol intake and the risk of stroke among young individuals in Korea.
A new drive is introduced with the help of a $6.6 million grant from the National Institutes of Health (NIH) for the Friedman School of Nutrition Science and Policy at Tufts University.
FDA has approved Gilead Science’s hepatitis B virus (HBV) drug Vemlidy for patients aged 12 and above. During clinical trials, the drug showed a reduction in DNA levels in 21% of patients.
A new alliance between Microsoft and Sophia Genetics intends to accelerate the transition to precision medicine throughout the world and improve data interoperability using Al and ML.
In order to build technologies, such as applications and wearables, that may not only assist consumers in recognising health risks like infectious viruses but also access resources for treatment, Evidation, a California-based digital health firm, has come up with FluSmart technology.
Researchers have examined the link between alcohol intake and the risk of stroke among young individuals in Korea.
A new drive is introduced with the help of a $6.6 million grant from the National Institutes of Health (NIH) for the Friedman School of Nutrition Science and Policy at Tufts University.
FDA has approved Gilead Science’s hepatitis B virus (HBV) drug Vemlidy for patients aged 12 and above. During clinical trials, the drug showed a reduction in DNA levels in 21% of patients.
A new alliance between Microsoft and Sophia Genetics intends to accelerate the transition to precision medicine throughout the world and improve data interoperability using Al and ML.
In order to build technologies, such as applications and wearables, that may not only assist consumers in recognising health risks like infectious viruses but also access resources for treatment, Evidation, a California-based digital health firm, has come up with FluSmart technology.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.